The association between breakfast frequency and diabetes incidence in middle-age women; the results of MTC study
Martínez CF, Stern D, Cortés-Valencia A, et al.
Nutr Metab Cardiovasc Dis. Pub. online 13 Jun 2024.
Leggi
The effect of eicosapentaenoic and docosahexaenoic acid supplementation on coronary artery calcium progression in subjects with diabetes and coronary artery disease: a secondary analysis of a randomized trial
Asbeutah AA, Daher R, Malik A, et al.
Am J Cardiol. Pub. online 15 Jun 2024.
Leggi
ANNALI AMD: REPORT ANALISI BUSINESS INTELLIGENCE – TERAPIA CON GLP1-RA
Carissimi Soci, siamo lieti di condividere il report dell’analisi di business intelligence, messo a punto dal gruppo Intelligenza Artificiale e basato sui dati degli Annali AMD: “Fotografia dei pazienti con diabete tipo 2 trattati con analoghi del GLP1 e modalità d’intensificazione terapeutica”. In letteratura vi sono molti studi sull'utilizzo in real life…
Leggi
AIFA: Riclassificazione KERENDIA (finerenone): medicinale soggetto a prescrizione medica limitativa, vendibile al pubblico su prescrizione di centri ospedalieri o di specialista endocrinologo, internista, geriatra e nefrologo (RRL). È istituito un piano terapeutico web-based
AIFA. 07/06/2024
Leggi
EASL-EASD-EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD): Executive Summary
European Association for the Study of the Liver; European Association for the Study of Diabetes; European Association for the Study of Obesity; Clinical Practice Guideline Panel
Diabetologia. Pub. Online13 Jun 2024.
Leggi
Treatment intensification following glucagon-like peptide-1 receptor agonists in type 2 diabetes: Comparative effectiveness analyses between different basal insulins. RESTORE-G real-world study
Napoli R, Nicolucci A, Larosa M, et al.
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi
Data-driven phenotyping of presymptomatic type 1 diabetes using longitudinal autoantibody profiles
Ghalwash M, Anand V, Ng K, et al.
Diabetes Care. Pub. online 11 Jun 2024.
Leggi
The quality of care in type 1 and type 2 diabetes – A 2023 update of the AMD Annals Initiative
Russo G, De Cosmo S, Di Bartolo P, et al.
Diabetes Res Clin Pract. Pub. online 13 Jun 2024.
Leggi
Efficacy and tolerability of initial triple combination therapy with metformin, dapagliflozin and saxagliptin compared with stepwise add-on therapy in drug-naïve patients with type 2 diabetes (TRIPLE-AXEL study): A multicentre, randomized, 104-week, open-label, active-controlled trial
Kim NH, Moon JS, Lee YH, et al.
Diabetes Obes Metab. Pub. online 11 Jun 2024.
Leggi
Cost–utility analysis of a flash continuous glucose monitoring system in the management of people with type 2 diabetes mellitus on basal insulin therapy—An Italian healthcare system perspective
Del Prato S, Giorgino F, Szafranski K, Poon Y
Diabetes Obes Metab. Pub. online 10 Jun 2024.
Leggi